Analysis of MRI radiomic features of hypoxic area in nasopharyngeal carcinoma patients
Kong Xudong1, Li Tengxiang2, Gong Guanzhong2
1Department of Radiation Oncology,Jiangnan University Hospital (Wuxi City Fourth People′s Hospital),Wuxi 214062,China; 2Department of Radiation Oncology,Shandong Cancer Hospital,Ji′nan 250000,China
Abstract：Objective To analyze the magnetic resonance imaging (MRI) radiomic performance of hypoxic area in nasopharyngeal carcinoma patients, aiming to provide a reference for identification and analysis of hypoxic area. Methods The MRI-T1, MRI-T2, MRI-T1+ and PET/CT images of 32 patients initially diagnosed with nasopharyngeal carcinoma were retrospectively analyzed. The gross tumor volume (GTV) of nasopharynx was countoured and the hypoxic areas (GTV-H) were identified by 18F-FMISO-PET images. The non-hypoxic areas (GTV-NH) were defined as the rest of areas removed GTV-H from GTV. The radiomic features of GTV-H and GTV-NH were extracted and compared. Results The average volume of GTV-H and GTV-NH was (10.92±11.02) cm3 and (7.21±5.70) cm3,respectively. The maximum rate of change was 46% for intensity direct-global min (ID-GM) on MRI-T1(P<0.05,AUC>0.7 and Youden index>0.5). The average rate of change was 136% for long run emphasis (LRE),long run high gray level emphasis (LRHGLE) and long run low gray level emphasis (LRLGLE) on MRI-T2(P<0.05,AUC>0.7 and Youden index>0.5). The high change rates was greater than 90% on MRI-T1+(P<0.05,AUC>0.7 and Youden index>0.5) for ID-GM,LRE,LRHGLE and LRLGLE. Conclusions The hypoxic area of tumor target can be reflected by MRI radiomics on T1/T2/T1+. Quantifying and tracking the variations of these features can bring benefit to recognize the hypoxic area of nasopharyngeal carcinoma tumor target.
Kong Xudong,Li Tengxiang,Gong Guanzhong. Analysis of MRI radiomic features of hypoxic area in nasopharyngeal carcinoma patients[J]. Chinese Journal of Radiation Oncology, 2019, 28(12): 924-927.
[1]Gillies RJ,Kinahan PE,Hricak H. Radiomics:images are more than pictures,They are data[J]. Radiology,2016, 278(2):563-577. DOI:10.1148/radiol.2015151169. [2]Li AC,Xiao WW,Wang L,et al. Risk factors and prediction-score model for distant metastasis in nasopharyngeal carcinoma treated with intensity-modulated radiotherapy[J]. Biol Med, 2015,36(11):8349-8357. DOI:10.1007/s13277-015-3574-0. [3]Skvortsov S,Jimenez CR,Knol JC,et al. Radioresistant head and neck squamous cell carcinoma cells:intracellular signaling,putative biomarkers for tumor recurrences and possible therapeutic targets[J]. Radiother Oncol,2011,101(1):177-182. DOI:10.1016/j.radonc.2011.05.067. [4]Wigerup C,Påhlman S,Bexell D. Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer[J]. Pharmacol Therapeut,2016,164(1):152-169. DOI:10.1016/j.pharmthera.2016.04.009. [5]Ou X,Cheng J,Zhang Y,et al. Preliminary results of 18F-FMISO PET in evaluating tumor hypoxia and predicting response to chemoradiation therapy in nasopharyngeal carcinoma[J]. Int J Radiat Oncol Biol Phys,2012,84(3):S486-S486. DOI:10.1016/j.ijrobp.2012.07.1289. [6]Zhang G,Wang W,Yao C,et al. Salinomycin overcomes radioresistance in nasopharyngeal carcinoma cells by inhibiting Nrf2 level and promoting ROS generation[J]. Biomed Pharmacother, 2017,91(1):147-154. DOI:10.1016/j.biopha.2017.04.095. [7]Zhang R,Song X,Liang C,et al. Catalase-loaded cisplatin-prodrug-constructed liposomes to overcome tumor hypoxia for enhanced chemo-radiotherapy of cancer[J]. Biomaterials,2017,138(1):13-21. DOI:10.1016/j.biomaterials.2017.05.025. [8]Rey S,Schito L,Koritzinsky M,et al. Molecular targeting of hypoxia in radiotherapy[J]. Adv Drug Deliv Rev,2017,109(1):45-62. DOI:10.1016/j.addr.2016.10.002. [9]Hendrickson K,Phillips M,Smith W,et al. Hypoxia imaging with[F-18] FMISO-PET in head and neck cancer:potential for guiding intensity modulated radiation therapy in overcoming hypoxia-induced treatment resistance[J]. Radiother Oncol,2011,101(3):369-375. DOI:10.1016/j.radonc.2011.07.029. [10]Matsuo M,Matsumoto S,Mitchell J B,et al. Magnetic resonance imaging of the tumor microenvironment in radiotherapy:perfusion,hypoxia,and metabolism[J]. Semin Radiat Oncol,2014,24(3):210-217. DOI:10.1016/j.semradonc.2014.02.002. [11]Zhang S,Zhang B,Tian J,et al. Radiomics features of multiparametric MRI as novel prognostic factors in advanced nasopharyngeal carcinoma[J]. Cancer Res,2017,23(15):4259-4269. DOI:10.1158/1078-0432. CCR-16-2910.
2019, Vol. 28 
